An adverse tumor-protective effect of IDO1 inhibition-Reference-Cited by-同舟云学术

An adverse tumor-protective effect of IDO1 inhibition

Published:2023-02 Issue:2 Volume:4 Page:100941
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Kenski Juliana C.N.,Huang Xinyao,Vredevoogd David W.,de Bruijn Beaunelle,Traets Joleen J.H.,Ibáñez-Molero Sofía,Schieven Sebastiaan M.,van Vliet Alex,Krijgsman Oscar,Kuilman Thomas,Pozniak Joanna,Loayza-Puch Fabricio,Terry Alexandra M.,Müller Judith,Logtenberg Meike E.W.,de Bruijn Marjolein,Levy Pierre,Körner Pierre-René,Goding Colin R.,Schumacher Ton N.,Marine Jean-Christophe,Agami Reuven,Peeper Daniel S.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference55 articles.

1. Primary, adaptive, and acquired resistance to cancer immunotherapy;Sharma;Cell,2017

2. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon;Yoshida;Proc. Natl. Acad. Sci. USA,1981

3. Studien über den intermediären Stoffwechsel des Tryptophans XVIII—XXIV;Kotake;Hoppe-Seyler's. Zeitschrift für. physiologische Chemie,1936

4. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase;Uyttenhove;Nat. Med.,2003

5. Ido expression in cancer: different compartment, different functionality?;Meireson;Front. Immunol.,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies;International Journal of Nanomedicine;2024-08

2. The significant role of amino acid metabolic reprogramming in cancer;Cell Communication and Signaling;2024-07-29

3. The high-affinity tryptophan uptake transport system in human cells;Biochemical Society Transactions;2024-05-30

4. The Interplay between Metabolic Adaptations and Diet in Cancer Immunotherapy;Clinical Cancer Research;2024-05-21

5. IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects;The Journal of Immunology;2024-02-23